| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Tarsus Pharmaceuticals (NASDAQ:TARS) through any online brokerage.
Other companies in Tarsus Pharmaceuticals’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Tarsus Pharmaceuticals has a consensus price target of $89.09.
The stock price for Tarsus Pharmaceuticals (NASDAQ: TARS) is $67.1 last updated October 16, 2026 at 7:21 PM EDT.
There are no upcoming dividends for Tarsus Pharmaceuticals.
Tarsus Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Tarsus Pharmaceuticals.
Tarsus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
